Biomarkers And Surrogate Endpoints In Drug Development

Biomarkers and Surrogate Endpoints in Drug Development

Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 1

Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More - Day 2

How Biomarkers Can Improve the Drug Development Process

U.S. Food and Drug Administration

Biomarkers of Drug Effects of Dr. Robert Schuck

NIH Clinical Center

endpoints, clinical trial outcomes, & surrogate endpoints

Use of Surrogate Endpoints in Oncology

Role of Biomarkers in Drug Development | Jeffrey Siegel

Arthritis Foundation

Surrogate endpoint biomarkers in research

HEAL Biomarker Webinar

Rare Disease Endpoint Advancement Pilot Program Workshop Day 1

The Role of Biomarkers in Clinical Trials

Advancing the Use of Biomarkers and Pharmacogenomics in Drug Development

Brookings Institution

What role can patients have in determining surrogate endpoints or biomarkers?

Premier Research

Drawn to Science | Biomarkers in drug discovery

Bench to Bedside: Episode 4 - "From Biomarker to Surrogate"

BioIndustry Association - BIA

IDDI WEBINAR: Statistical Validation of Biomarkers

IDDI

Biomarkers and Drug Development: Regulatory Perspective | Christopher Leptak

Foresight Institute

Biomarkers in NASH Drug Development

DiaPharma Group, Inc.

#NIHHEAL: Endpoints for Pain Clinical Trials — Approaches & Accepted Endpoints for Biomarker Devices

National Institutes of Health (NIH)